Markets:

Overview

News

Currencies

International

Treasuries

Vertex Pharmaceuticals (NQ:VRTX)

469.27 UNCHANGED

Streaming Delayed Price Updated: 4:00 PM EST, Feb 19, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Vertex Pharmaceuticals

< Previous 1 2

...

19 20 21 22 23 24 25 26 27

...

63 64 Next >

Smart Money Is Betting Big In VRTX Options ↗

May 06, 2024

Via Benzinga

3 No-Brainer Stocks to Buy in May ↗

May 05, 2024

These great stocks are great picks for investors as spring winds down.

Via The Motley Fool

3 Biotech Stocks With the Potential to Make You an Overnight Millionaire ↗

May 04, 2024

Don’t miss out on these stocks that could rock your portfolio with massive growth following FDA approvals and breakthrough treatments.

Via InvestorPlace

A Week Of Fast-Moving Stocks Ahead: Disney, Toyota, Ferrari, Constellation ↗

May 03, 2024

Earnings season moves into final innings, some fast-moving names led by Disney, Ferrari and Constellation report.

Via Investor's Business Daily

Shhh! 3 Secret Gene Editing Stocks Flying Below Wall Street’s Radar ↗

May 03, 2024

The gene editing stocks are worth tuning into as some investors out there discount their innovative, albeit early-stage pipelines.

Via InvestorPlace

(VRTX) - Analyzing Vertex Pharmaceuticals's Short Interest ↗

April 25, 2024

Via Benzinga

2 Fantastic Growth Stocks to Buy Right Now ↗

April 25, 2024

Don't overlook these high-growth businesses.

Via The Motley Fool

If You Invested $1000 In This Stock 10 Years Ago, You Would Have $6,000 Today ↗

April 16, 2024

Via Benzinga

3 Growth Stocks You’ll Kick Yourself for Not Buying Today ↗

May 03, 2024

Netflix, Intuit, and Vertex Pharmaceuticals are three growth stocks to buy, each positioned for significant market share and returns.

Via InvestorPlace

Shhh! 3 Secret Pharma Stocks Flying Below Wall Street’s Radar ↗

May 03, 2024

Discover three under-the-radar pharma stocks poised for significant growth in 2024. Explore their product pipelines and potential gains.

Via InvestorPlace

Here's How Much You Would Have Made Owning Vertex Pharmaceuticals Stock In The Last 10 Years ↗

May 02, 2024

Via Benzinga

2 Top Growth Stocks to Buy Right Now and Hold Forever ↗

April 28, 2024

These healthcare stocks can provide enviable long-term portfolio growth.

Via The Motley Fool

Want $1 Million in Retirement? 3 Stocks to Buy Now And Hold for Decades. ↗

April 27, 2024

These three should have a lot of room to run.

Via The Motley Fool

The Analyst Landscape: 16 Takes On Vertex Pharmaceuticals ↗

April 12, 2024

Via Benzinga

$100B Vertex Pharma Working To Recreate $10B Cystic Fibrosis Success - This Time Focused On Pain Management Drugs ↗

April 26, 2024

Unlock Vertex Pharmaceuticals' pioneering treatments, from the groundbreaking Trikafta for cystic fibrosis to the promising non-opioid painkillers.

Via Benzinga

Missed Out on Novo Nordisk? 2 Healthcare Stocks With Big Catalysts on the Horizon. ↗

April 24, 2024

Good news could be just around the corner for two drugmakers not named Novo Nordisk.

Via The Motley Fool

Vertex Pharmaceuticals Just Made 2 Big Moves. Is the Stock a Buy? ↗

April 23, 2024

Vertex is broadening its portfolio.

Via The Motley Fool

Making Sense of Amazon CEO Andy Jassy's Latest Letter ↗

April 22, 2024

And that's just part of the interesting news for investors to dig into.

Via The Motley Fool

If You'd Invested $10,000 in Vertex Pharmaceuticals 5 Years Ago, Here's How Much You'd Have Today ↗

April 22, 2024

Could Vertex's growth story continue?

Via The Motley Fool

Looking for Once-in-a-Generation Investment Opportunities? Here Are 3 Magnificent Stocks to Buy Right Now ↗

April 22, 2024

These stocks could be near major inflection points.

Via The Motley Fool

2 Everlasting Big Pharma Stocks to Buy Today and Hold Forever ↗

April 20, 2024

These stocks probably won't be getting much cheaper.

Via The Motley Fool

3 Relatively Safe Growth Stocks You Can Buy and Hold ↗

April 20, 2024

Low risk and high-reward potential? These stocks could offer both.

Via The Motley Fool

3 Biotech Stocks Set to Double by 2028 ↗

April 20, 2024

These are three of the top biotech stocks set to double by 2028. Add them to your portfolio to maximize your potential gains.

Via InvestorPlace

Is Vertex Pharmaceuticals Stock a Millionaire Maker? ↗

April 19, 2024

Does this pharma stock have the potential to turn a $25,000 investment into seven figures or more?

Via The Motley Fool

Tesla To $123? Here Are 10 Top Analyst Forecasts For Thursday ↗

April 18, 2024

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

Via Benzinga

Does This Acquisition Make Vertex Pharmaceuticals Stock a Buy? ↗

April 18, 2024

The biotech just added another potential growth driver to its pipeline.

Via The Motley Fool

Here's (at Least) 1 new Reason to Buy Vertex Pharmaceuticals Stock ↗

April 15, 2024

Vertex just laid claim to an asset that might be very valuable.

Via The Motley Fool

Could This Stock Be the Next Biotech Buyout? ↗

April 13, 2024

Vertex Pharmaceuticals' $4.9 billion purchase of Alpine Immune Sciences probably won't be the last acquisition of a company focused on kidney disease.

Via The Motley Fool

Stock Market Sends Mixed Signals; Nvidia, Inflation, Mideast Fears In Focus: Weekly Review ↗

April 12, 2024

The stock market gave some bullish signs, with Nvidia rebounding, but the indexes generally fell for the week on inflation and Mideast fears.

Via Investor's Business Daily

Topics Economy

Vertex's Alpine Acquisition: Unpacking Analyst Predictions on Povetacicept's Potential Impact ↗

April 11, 2024

Vertex Pharmaceuticals to acquire Alpine Immune Sciences for $4.9 billion, expanding into nephrology with promising APOL1-mediated kidney disease treatments. Analysts foresee significant revenue growth...

Via Benzinga

< Previous 1 2

...

19 20 21 22 23 24 25 26 27

...

63 64 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Vertex Pharmaceuticals (NQ:VRTX)

Headline News about Vertex Pharmaceuticals

Starting at $3.75/week.

Subscribe Today